VEGFA and retinal disorder: Small molecule inhibitors of SRPK1, known as SRPIN340 and SPHINX31, have been shown to upregulate the VEGF-Axxxb isoforms relative to VEGF-Axxxa, which had a therapeutic effect in animal models of retinopathy [137,138].